REKLAMA
WAKACJE NA GIEŁDZIE

SOPHARMA AD: Consolidated financial statements for the nine months of 2025

2025-11-28 13:59
publikacja
2025-11-28 13:59
Dodaj Bankier.pl w Google
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_Q3_2025_cons_Financial statements.rar

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No

230

/

2025

Date of issue:

2025-11-28

Short name of the issuer

SOPHARMA AD

Subject

Consolidated financial statements for the nine months of 2025

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Consolidated financial statements for the nine months of 2025

Annexes

File

Description

SFA_Q3_2025_cons_Financial statements.rar

Consolidated financial statements for the nine months of 2025

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification

of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date

Name

Position / Function

Signature

2025-11-28

Ognian Ivanov Donev

Executive Director

Źródło:Komunikaty spółek (ESPI)
Tematy

Komentarze (0)

dodaj komentarz

Powiązane:

Polecane

Najnowsze

Popularne

Ważne linki